Subscribe for great stories in your community!
A growing number of local pharmaceutical, biotech, and medical device companies are joining efforts to develop a COVID-19 vaccine, writes John George for the…
King of Prussia’s Trevena is making headway on its Oliceridine painkiller which could provide a safer opioid alternative to current drug treatments, writes Laurel…
Two centuries after pharmacists first isolated morphine from opium, a King of Prussia pharmaceutical company is on the brink of offering a non-addictive alternative…
Located in King of Prussia, Trevena is a publicly-traded, clinical-stage biopharmaceutical company dedicated to the discovery and development of groundbreaking new medicines. Established…
Trevena, a King of Prussia-based biopharmaceutical company, has started two late-stage clinical trials on its experimental pain medicine, oliceirdine, writes John George for…
The 2008-2009 recession left its mark on Montgomery County, but thanks to new jobs created in construction, health care, and professional services, the area…
Before we send you to this site, please subscribe to our daily newsletter.